• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    10x Genomics, Inc. - Common Stock (NQ:TXG)

    52.03 +6.43 (+14.10%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 5,433,036
    Open 45.51
    Bid (Size) 51.31 (100)
    Ask (Size) 51.93 (100)
    Prev. Close 45.60
    Today's Range 44.39 - 52.22
    52wk Range 11.16 - 52.22
    Shares Outstanding 109,588,527
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    10x Genomics Q2 Earnings Call Highlights ↗
    10x Genomics (NASDAQ:TXG) reported second-quarter revenue of $151 million, including $1.6 million in license and royalty revenue tied to its settlement with Takara. Excluding non-recurring settlement... 
    Via MarketBeat
    Topics Earnings
    News headline image
    TXG Q2 Deep Dive: Atera Launch Signals Transition as Spatial Market Shifts
    Biotech company 10x Genomics (NASDAQ:TXG) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 12.6% year on year to $15... 
    Via StockStory
    Topics Artificial Intelligence

    Performance

    YTD
    +213.1%
    +213.1%
    1 Month
    +37.5%
    +37.5%
    3 Month
    +132.1%
    +132.1%
    6 Month
    +194.0%
    +194.0%
    1 Year
    +311.0%
    +311.0%

    More News

    Read More
    News headline image
    1 Unpopular Stock That Deserves Some Love and 2 That Underwhelm
    Via StockStory
    News headline image
    10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations
    Via StockStory
    News headline image
    10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
    Via StockStory
    News headline image
    1 Surging Stock with Solid Fundamentals and 2 Facing Headwinds
    Via StockStory
    News headline image
    1 Healthcare Stock to Keep an Eye On and 2 We Avoid
    Via StockStory
    News headline image
    Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
    Via StockStory
    News headline image
    1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges
    Via StockStory
    News headline image
    3 Russell 2000 Stocks We Steer Clear Of
    Via StockStory
    News headline image
    3 Cash-Heavy Stocks We Find Risky
    Via StockStory
    News headline image
    Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    1 Unprofitable Stock on Our Watchlist and 2 We Brush Off
    Via StockStory
    News headline image
    Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Why Is 10x Genomics (TXG) Stock Soaring Today
    Via StockStory
    News headline image
    10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?
    Via StockStory
    Topics Supply Chain
    News headline image
    3 Small-Cap Stocks with Questionable Fundamentals
    Via StockStory
    News headline image
    10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call
    Via StockStory
    Topics Artificial Intelligence Earnings
    News headline image
    United Natural Foods Stock Is Up 85%. One Investor Just Sold Out Completely ↗
    Via The Motley Fool
    Topics Economy Supply Chain
    News headline image
    What to Know About This Fund’s Sale of a Pharma Stock Up 56% in a Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% ↗
    Via The Motley Fool
    News headline image
    1 Cash-Producing Stock on Our Watchlist and 2 We Question
    Via StockStory
    News headline image
    10x Genomics Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Why 10x Genomics (TXG) Stock Is Down Today
    Via StockStory

    Frequently Asked Questions

    Is 10x Genomics, Inc. - Common Stock publicly traded?
    Yes, 10x Genomics, Inc. - Common Stock is publicly traded.
    What exchange does 10x Genomics, Inc. - Common Stock trade on?
    10x Genomics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for 10x Genomics, Inc. - Common Stock?
    The ticker symbol for 10x Genomics, Inc. - Common Stock is TXG on the Nasdaq Stock Market
    What is the current price of 10x Genomics, Inc. - Common Stock?
    The current price of 10x Genomics, Inc. - Common Stock is 52.03
    When was 10x Genomics, Inc. - Common Stock last traded?
    The last trade of 10x Genomics, Inc. - Common Stock was at 08/07/26 04:00 PM ET
    What is the market capitalization of 10x Genomics, Inc. - Common Stock?
    The market capitalization of 10x Genomics, Inc. - Common Stock is 5.70B
    How many shares of 10x Genomics, Inc. - Common Stock are outstanding?
    10x Genomics, Inc. - Common Stock has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.